Grandfield & Dodd »

Iovance Biotherapeutics shares owned by Grandfield & Dodd

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Grandfield & Dodd from 13F filings

Historical chart of Grandfield & Dodd investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Grandfield & Dodd consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Grandfield & Dodd

Quarter filed Position value Share count Share price at filing
2024-09-30 $282k 30k 9.39

More positions owned by Grandfield & Dodd

Microsoft Corporation (MSFT)
Analog Devices (ADI)
Linde SHS (LIN)
Ge Aerospace Com New (GE)
Paychex (PAYX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Johnson Ctls Intl SHS (JCI)
Chubb (CB)
Raytheon Technologies Corp (RTX)
Caci Intl Cl A (CACI)
Illinois Tool Works (ITW)
Applied Materials (AMAT)
Autodesk (ADSK)
Verisk Analytics (VRSK)
Stryker Corporation (SYK)

View all positions for Grandfield & Dodd

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics